A market only a third penetrated

The opportunity begins with how few Indians who need glasses actually own a proper pair. Eyeglass penetration sits at just 35 percent, against 69 percent in Japan and 88 percent in the United States — each square below is one percentage point of the Indian population.

The tailwinds are structural. Refractive errors are set to afflict 62 percent of Indians by FY30 — as high as 75 percent among teenagers and children — from 43 percent in FY20. As awareness rises and buyers shift to organised brands, whose share is seen climbing to 31 percent by FY30 from 22 percent in FY20, the domestic eyewear market is projected to grow at a 13 percent compound rate — roughly three times the pace of the global industry — from Rs 78,800 crore in FY25 to about Rs 1,48,300 crore by FY30. Lenskart holds only about 5 percent of it today.

The moat: making eyewear for less

Lenskart's edge is that it owns the entire chain. Its Bhiwadi facility — running at 75 percent automation — integrates procurement, lens coating, edging, cutting, polishing, assembly and dispatch, while AI-led design, remote eye-testing and an omnichannel platform speed innovation and cut cost. The result is a structural price advantage: frame and lens costs run 35 to 40 percent below the Indian industry average, letting Lenskart sell 50 to 70 percent cheaper than local opticians.

That integration is deepening. Prescription eyeglasses made at its centralised plants rose to 1.75 crore units in FY26 from 1.01 crore in FY24; in-house frames climbed to 78 lakh from 53 lakh and lenses to 56 lakh from 25 lakh. A new Hyderabad facility will add roughly 5 crore units of capacity on top of the current 2.5 crore, extending the cost advantage as volumes scale. Cheap, reliable supply has helped annual transacting customers roughly double to 1.6 crore in FY26 from 77 lakh in FY23.

A house of brands on an omnichannel net

Above the supply chain sits a multi-brand storefront, each label aimed at a different customer and occasion but sharing Lenskart's technology, sourcing and distribution.

India, about 60 percent of revenue, remains the core, with international markets — led by Japan and Southeast Asia — the other 40 percent. Ambition is scaling in step: management aims to run 10 crore eye tests a year, up from roughly 2 crore today.

From losses to compounding profit

The financial arc is the clincher. Revenue has compounded at 33 percent to Rs 8,814 crore over FY23-26, but the sharper move is in profitability: EBITDA margins have widened from 7 percent in FY23 to 19.9 percent in FY26, dragging the business from a small loss to real earnings.

Looking ahead, ICICI expects revenue, EBITDA and net profit to compound at 27, 37 and 59 percent respectively over FY26-29E, with margins reaching 25 percent and return on capital employed climbing to 28 percent. Net profit swings from a marginal loss in FY24 to about Rs 2,058 crore by FY29E, and the company is expected to throw off cumulative free cash flow of roughly Rs 5,300 crore across the period.

The target for investors

ICICI Securities initiates with a BUY and a target of Rs 850, an upside of roughly 23 percent, valuing Lenskart at 43 times FY28E operating profit. This is unambiguously a premium-multiple growth stock — it trades at around 234 times FY26 earnings, easing to about 58 times on FY29E estimates as profits compound — so the case rests on execution rather than cheapness. With the stock near its 52-week high of Rs 698 after a powerful run off the Rs 356 low, the measured approach is to accumulate on market-linked dips and hold for the multi-year penetration and margin story, rather than chase the price.

Key risks